Inventiva S.A. (EPA:IVA)
2.580
+0.160 (6.61%)
Feb 21, 2025, 5:35 PM CET
Inventiva Employees
As of December 31, 2023, Inventiva had 123 total employees, including 120 full-time and 3 part-time employees. The number of employees increased by 10 or 8.85% compared to the previous year.
Employees
123
Change (1Y)
10
Growth (1Y)
8.85%
Revenue / Employee
€156,707
Profits / Employee
€847,041
Market Cap
246.81M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
EssilorLuxottica Société anonyme | 200,000 |
Sanofi | 82,878 |
Sartorius Stedim Biotech | 10,662 |
bioMérieux | 13,982 |
Eurofins Scientific SE | 63,000 |
Ipsen | 5,325 |
Virbac | 5,459 |
emeis Société anonyme | 77,954 |
Inventiva News
- 1 day ago - Inventiva and Hepalys Pharma, Inc. announce the initiation of the clinical development program of lanifibranor in Japan with the dosing of the first participant in Phase 1 trial - GlobeNewsWire
- 11 days ago - Inventiva reports preliminary 2024 fiscal year financial results¹ and provides a business update - GlobeNewsWire
- 23 days ago - Inventiva announces the publication of the results from the investigator-initiated proof-of-concept clinical trial evaluating lanifibranor in patients with T2D and MASLD in the Journal of Hepatology - GlobeNewsWire
- 4 weeks ago - Half-Year Review of Inventiva's Liquidity Contract with Kepler Cheuvreux - GlobeNewsWire
- 4 weeks ago - Results of LEGEND evaluating lanifibranor in combination with empagliflozin in MASH selected for oral presentation at the upcoming EASL SLD Summit 2025 - GlobeNewsWire
- 2 months ago - Inventiva to present at the 43rd Annual J.P. Morgan Healthcare Conference - GlobeNewsWire
- 2 months ago - Inventiva secures €21.4 million - Seeking Alpha
- 2 months ago - Inventiva secures €21.4 million and completes the first tranche of the previously announced multi-tranche financing of up to €348 million - GlobeNewsWire